Literature DB >> 12115695

Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts.

Mark H Tuszynski1, Ray Grill, Leonard L Jones, Heather M McKay, Armin Blesch.   

Abstract

Little is known about molecular and cellular responses to spinal cord injury in primates. In this study, the normal milieu of the primate spinal cord was disturbed by multiple needle penetrations and cell injections in the mid-thoracic spinal cord; subsequent effects on local axons and expression of extracellular matrix (ECM) molecules were examined, together with effects of cellular delivery of nerve growth factor (NGF) to the injured region. Four adult rhesus monkeys each received injections of two grafts of autologous fibroblasts genetically modified to secrete human NGF, and, in control injection sites, two separate grafts of autologous fibroblasts transduced to express the reporter gene, beta-galactosidase. Three months later, Schwann cells extensively infiltrated the region of localized injury and penetrated both NGF and control fibroblast grafts. Marked upregulation of several ECM molecules occurred, including chondroitin and heparan sulfate proteoglycans and type IV collagen, in or adjacent to all injection sites. Schwann cells were an apparent source of some ECM expression. Spinal cord sensory axons and putative coerulospinal axons extended into both graft types, but they penetrated NGF grafts to a significantly greater extent. Many of these axons expressed the cell adhesion molecule L1. Thus, extensive cellular and molecular changes occur at sites of localized primate spinal cord injury and grafting, attributable in part to migrating Schwann cells, and are accompanied by spontaneous axonal plasticity. These molecular and cellular events closely resemble those observed in the rodent spinal cord after injury. Furthermore, as in rodent studies, cellular delivery of a trophic factor significantly augments axonal plasticity in the primate spinal cord. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115695     DOI: 10.1002/cne.10266

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  17 in total

1.  In vivo tracing of neural tracts in the intact and injured spinal cord of marmosets by diffusion tensor tractography.

Authors:  Kanehiro Fujiyoshi; Masayuki Yamada; Masaya Nakamura; Junichi Yamane; Hiroyuki Katoh; Kazuya Kitamura; Kenji Kawai; Seiji Okada; Suketaka Momoshima; Yoshiaki Toyama; Hideyuki Okano
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

2.  Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?

Authors:  Grégoire Courtine; Mary Bartlett Bunge; James W Fawcett; Robert G Grossman; Jon H Kaas; Roger Lemon; Irin Maier; John Martin; Randolph J Nudo; Almudena Ramon-Cueto; Eric M Rouiller; Lisa Schnell; Thierry Wannier; Martin E Schwab; V Reggie Edgerton
Journal:  Nat Med       Date:  2007-05       Impact factor: 53.440

Review 3.  Animal models of neurologic disorders: a nonhuman primate model of spinal cord injury.

Authors:  Yvette S Nout; Ephron S Rosenzweig; John H Brock; Sarah C Strand; Rod Moseanko; Stephanie Hawbecker; Sharon Zdunowski; Jessica L Nielson; Roland R Roy; Gregoire Courtine; Adam R Ferguson; V Reggie Edgerton; Michael S Beattie; Jacqueline C Bresnahan; Mark H Tuszynski
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain.

Authors:  Lone Fjord-Larsen; Philip Kusk; Jens Tornøe; Bengt Juliusson; Malene Torp; Carsten R Bjarkam; Mette S Nielsen; Aase Handberg; Jens Christian H Sørensen; Lars U Wahlberg
Journal:  Mol Ther       Date:  2010-07-27       Impact factor: 11.454

5.  Local and remote growth factor effects after primate spinal cord injury.

Authors:  John H Brock; Ephron S Rosenzweig; Armin Blesch; Rod Moseanko; Leif A Havton; V Reggie Edgerton; Mark H Tuszynski
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

Review 6.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

7.  Assembly of protein-based hollow spheres encapsulating a therapeutic factor.

Authors:  Honorata Kraskiewicz; Bridget Breen; Timothy Sargeant; Siobhan McMahon; Abhay Pandit
Journal:  ACS Chem Neurosci       Date:  2013-07-08       Impact factor: 4.418

Review 8.  Curiosity and cure: translational research strategies for neural repair-mediated rehabilitation.

Authors:  Bruce H Dobkin
Journal:  Dev Neurobiol       Date:  2007-08       Impact factor: 3.964

9.  Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Authors:  Nadine Mestre-Francés; Nicolas Serratrice; Aurélie Gennetier; Gina Devau; Sandra Cobo; Stéphanie G Trouche; Pascaline Fontès; Charleine Zussy; Philippe De Deurwaerdere; Sara Salinas; Franck Jd Mennechet; Julien Dusonchet; Bernard L Schneider; Isabella Saggio; Vasiliki Kalatzis; M Rosario Luquin-Piudo; Jean-Michel Verdier; Eric J Kremer
Journal:  JCI Insight       Date:  2018-07-26

10.  Axon growth across a lesion site along a preformed guidance pathway in the brain.

Authors:  Ying Jin; Kristine S Ziemba; George M Smith
Journal:  Exp Neurol       Date:  2007-12-23       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.